We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$1.74B
AUM Growth
+$18.9M
Cap. Flow
-$61.5M
Cap. Flow %
-3.53%
Top 10 Hldgs %
23.9%
Holding
276
New
11
Increased
44
Reduced
193
Closed
16

Top Buys

Rank Stock Value
1
OABI icon
OmniAb
OABI
+$13M
2
DOCS icon
Doximity
DOCS
+$10.2M
3
LOB icon
Live Oak Bancshares
LOB
+$7.32M
4
RXO icon
RXO
RXO
+$7.31M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$6.78M

Top Sells

Rank Stock Value
1
AERI
Aerie Pharmaceuticals
AERI
+$24.3M
2
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$12.4M
3
LGND icon
Ligand Pharmaceuticals
LGND
+$12.3M
4
XPO icon
XPO
XPO
+$7.84M
5
RXT icon
Rackspace Technology
RXT
+$5.42M

Sector Composition

Rank Sector Weight
1 Technology 27.01%
2 Healthcare 26.13%
3 Industrials 15.45%
4 Consumer Discretionary 11.41%
5 Communication Services 6.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WNS
1
DELISTED
WNS Holdings
WNS
$54.2M 3.11%
677,602
-13,410
-2% -$1.11M
DFIN icon
2
Donnelley Financial Solutions
DFIN
$1.21B
$45.2M 2.59%
1,168,484
-8,261
-0.7% -$310K
DOOR
3
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$42.8M 2.45%
530,672
-6,478
-1% -$479K
MEDP icon
4
Medpace
MEDP
$16B
$42.1M 2.42%
198,251
-7,671
-4% -$1.53M
EEFT icon
5
Euronet Worldwide
EEFT
$2.77B
$41.4M 2.37%
438,633
-14,642
-3% -$1.27M
PBH icon
6
Prestige Consumer Healthcare
PBH
$2.35B
$39.2M 2.25%
626,159
-841
-0.1% -$48.2K
LRN icon
7
Stride
LRN
$3.48B
$38.5M 2.21%
1,232,006
-19,300
-2% -$709K
WWE
8
DELISTED
World Wrestling Entertainment
WWE
$38.4M 2.2%
560,665
-393
-0.1% -$29.7K
ZD icon
9
Ziff Davis
ZD
$1.92B
$38.1M 2.18%
481,436
-386
-0.1% -$31.1K
ACIW icon
10
ACI Worldwide
ACIW
$5.81B
$36.9M 2.12%
1,605,156
-54,271
-3% -$1.17M
MED icon
11
Medifast
MED
$108M
$31M 1.78%
269,097
-3,773
-1% -$439K
PINC
12
DELISTED
Premier
PINC
$30.6M 1.75%
874,132
-1,102
-0.1% -$36.7K
APPS icon
13
Digital Turbine
APPS
$971M
$28.6M 1.64%
1,874,488
+114,670
+7% +$1.76M
AX icon
14
Axos Financial
AX
$5.69B
$25.6M 1.47%
669,948
-1,865
-0.3% -$71.1K
NGVT icon
15
Ingevity
NGVT
$2.48B
$25.3M 1.45%
359,496
-4,436
-1% -$313K
AGM icon
16
Federal Agricultural Mortgage
AGM
$2.38B
$22.8M 1.31%
202,408
-3,799
-2% -$437K
SUPN icon
17
Supernus Pharmaceuticals
SUPN
$2.6B
$22.1M 1.27%
619,327
-59,984
-9% -$2.08M
SSTK icon
18
Shutterstock
SSTK
$196M
$21.5M 1.23%
407,751
-2,890
-0.7% -$147K
LCII icon
19
LCI Industries
LCII
$2.46B
$21.4M 1.23%
231,113
-748
-0.3% -$73.4K
CMBM
20
DELISTED
Cambium Networks
CMBM
$20M 1.15%
921,565
-15,040
-2% -$303K
RDWR icon
21
Radware
RDWR
$1.07B
$19.6M 1.12%
991,216
-41,200
-4% -$862K
LGND icon
22
Ligand Pharmaceuticals
LGND
$5.84B
$19.1M 1.09%
285,634
-189,941
-40% -$12.3M
MTN icon
23
Vail Resorts
MTN
$5.39B
$18.7M 1.07%
78,612
-90
-0.1% -$21.1K
AWI icon
24
Armstrong World Industries
AWI
$7.31B
$18.1M 1.04%
263,980
-3,623
-1% -$274K
DOCS icon
25
Doximity
DOCS
$3.75B
$18.1M 1.04%
539,077
+334,166
+163% +$10.2M
1
2 3 4 5

Similar funds

GC
Gobi Capital San Francisco, California $1.8B AUM 7.28% 1-Year Est. Return
BP
BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return
CIM
Cambria Investment Management Manhattan Beach, California $1.79B AUM 28.1% 1-Year Est. Return
JCM
Jacobi Capital Management Pittston, Pennsylvania $1.79B AUM 17.94% 1-Year Est. Return
KPM
Kinetic Partners Management Miami, Florida $1.79B AUM 57.3% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return
ST
Spinnaker Trust Portland, Maine $1.81B AUM 17.83% 1-Year Est. Return
MCC
Money Concepts Capital Palm Beach Gardens, Florida $1.81B AUM 21.93% 1-Year Est. Return

Rice Hall James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Rice Hall James & Associates held 276 positions worth $1.74B, up 1.1% from $1.72B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates withdrew a net $61.5M in Q4 2022, closing 16 positions and reducing 193 holdings. Its most notable exit was Aerie Pharmaceuticals, an estimated $24.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in OmniAb worth $8.94M.

  • Rice Hall James & Associates's largest Q4 2022 buy was OmniAb: 2,483,766 shares worth $8.94M.
  • Rice Hall James & Associates added most to Doximity in Q4 2022, an estimated $10.2M increase.
  • Rice Hall James & Associates's biggest Q4 2022 reduction was Ligand Pharmaceuticals, cutting an estimated $12.3M.
  • Rice Hall James & Associates fully exited Aerie Pharmaceuticals in Q4 2022, selling an estimated $24.3M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $1.74B portfolio in Q4 2022.
  • Rice Hall James & Associates opened 11 new positions and closed 16 in Q4 2022.
  • Rice Hall James & Associates's portfolio value rose 1.1% quarter-over-quarter to $1.74B.

Based on Rice Hall James & Associates's 13F filing for Q4 2022, filed 27 Jan 2023.